In our validation cohort, the levels of MBD2 in tumor and adjacent tissues were significantly associated with the postoperative survival of HCC although no significant difference was observed in the level of MBD2 between tumor tissues and adjacent tissues. This evidence concerns the gene MBD2 and hepatocellular carcinoma.